What's breaking now, across thousands of outlets.
Kinder Morgan continues to secure new expansion projects.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS.
Goldsberry says the program will create jobs, not cut them.
CAPE TOWN, Oct 23 — South African writer Coral Hart has published more than 370 books since February 2025 using ar...
Nvidia CEO Jensen Huang is pitching the concept of “sovereign AI” in Kazakhstan – part of his global crusade urging nations to build domestic computing infrastructure using the firm’s chips – as the…
